International Joint Center for Biomedical Innovation (JCBI)     International Joint Center for Biomedical Innovation (JCBI)
Position: JCBI HOME/News/Content
Dr. David Lovejoy visited JCBI

Dr. David Lovejoy visited JCBI on July 11. During this period, he had in-depth communication with teachers and students from JCBI and shared his years of research experience. Then, he visited the experiment and instrument platform of JCBI.

Dr. David Lovejoy has been engaged in research on medical chemistry and biomedical. By far, he has more than 50 publications in top ranked international research journals including Blood, Cancer Research etc. He has led or participated in more than 30 scientific research projects and was accredited 2 patents. Dr. David Lovejoy also equipped with extensive experience in the application of scientific research results. The cancer treatment molecule: DpC, which was designed and synthesized by Lovejoy himself, has engaged in phase 1 clinical trials. In addition, Dr. David Lovejoy founded Oncochel Therapeutics LLC (USA), a company dedicated to translating scientific research in biomedical related fields into social benefits.

 International Joint Center
for Biomedical Innovation (JCBI)
School of Life Sciences, Henan University, Jin Ming Avenue, Kaifeng, Henan, 475004, China